Riverbridge Partners’s US Physical Therapy USPH Stock Holding History

Riverbridge Partners’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-283,261	Closed	-$20.5M	–	190
2025 Q1	$20.5M	Sell	283,261 -26,949	-9%	-$2.26M	0.33%	80
2024 Q4	$27.5M	Sell	310,210 -25,921	-8%	-$2.31M	0.38%	76
2024 Q3	$28.4M	Sell	336,131 -11,668	-3%	-$1.04M	0.38%	79
2024 Q2	$32.1M	Sell	347,799 -28,926	-8%	-$2.93M	0.44%	71
2024 Q1	$42.5M	Sell	376,725 -10,753	-3%	-$1.07M	0.52%	65
2023 Q4	$36.1M	Sell	387,478 -5,890	-1%	-$519K	0.45%	69
2023 Q3	$36.1M	Sell	393,368 -7,052	-2%	-$757K	0.49%	68
2023 Q2	$48.6M	Sell	400,420 -8,484	-2%	-$915K	0.61%	62
2023 Q1	$40M	Buy	408,904 +6,682	+2%	+$638K	0.56%	64
2022 Q4	$32.6M	Sell	402,222 -4,649	-1%	-$390K	0.49%	71
2022 Q3	$30.9M	Sell	406,871 -3,046	-0.7%	-$293K	0.46%	76
2022 Q2	$44.8M	Sell	409,917 -12,441	-3%	-$1.32M	0.72%	54
2022 Q1	$42M	Buy	422,358 +41,012	+11%	+$3.91M	0.47%	72
2021 Q4	$36.4M	Buy	381,346 +12,295	+3%	+$1.23M	0.36%	85
2021 Q3	$40.8M	Sell	369,051 -1,413	-0.4%	-$161K	0.41%	80
2021 Q2	$42.9M	Buy	370,464 +16,570	+5%	+$1.9M	0.44%	86
2021 Q1	$36.8M	Sell	353,894 -30,274	-8%	-$3.76M	0.42%	79
2020 Q4	$46.2M	Buy	384,168 +35,879	+10%	+$3.62M	0.51%	66
2020 Q3	$30.3M	Sell	348,289 -11,936	-3%	-$1.03M	0.42%	74
2020 Q2	$29.2M	Sell	360,225 -10,358	-3%	-$755K	0.46%	70
2020 Q1	$25.6M	Sell	370,583 -2,835	-0.8%	-$299K	0.54%	65
2019 Q4	$42.7M	Sell	373,418 -6,930	-2%	-$863K	0.77%	50
2019 Q3	$49.7M	Sell	380,348 -7,896	-2%	-$1.03M	0.94%	41
2019 Q2	$47.6M	Sell	388,244 -13,112	-3%	-$1.51M	0.9%	43
2019 Q1	$42.2M	Sell	401,356 -54,682	-12%	-$5.88M	0.82%	46
2018 Q4	$46.7M	Sell	456,038 -17,442	-4%	-$1.94M	0.97%	39
2018 Q3	$56.2M	Sell	473,480 -20,906	-4%	-$2.36M	0.94%	43
2018 Q2	$47.5M	Buy	494,386 +154,915	+46%	+$14.4M	0.86%	46
2018 Q1	$27.6M	Buy	339,471 +4,493	+1%	+$348K	0.5%	70
2017 Q4	$24.2M	Sell	334,978 -10,204	-3%	-$696K	0.47%	73
2017 Q3	$21.2M	Sell	345,182 -49,512	-13%	-$3.02M	0.42%	77
2017 Q2	$23.8M	Sell	394,694 -24,070	-6%	-$1.54M	0.46%	74
2017 Q1	$27.3M	Sell	418,764 -13,167	-3%	-$933K	0.55%	66
2016 Q4	$30.3M	Buy	+431,931	New	+$27.5M	0.63%	60

Other funds holding USPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Riverbridge Partners's USPH Position: Q2 2025 in Review

Riverbridge Partners sold out of US Physical Therapy (USPH) in Q2 2025, closing a stake of 283,261 shares — an estimated $20.5M sold.

Riverbridge Partners first reported a position in USPH in Q4 2016 and held it in 34 quarters. The position peaked at $56.2M in Q3 2018. 240 funds tracked by Wall St. Rank hold USPH as of Q2 2025.

Riverbridge Partners reported no remaining US Physical Therapy position as of Q2 2025 after selling out during the quarter.
Riverbridge Partners sold 283,261 US Physical Therapy shares in Q2 2025, an estimated $20.5M.
Riverbridge Partners first reported a position in US Physical Therapy in Q4 2016 and held it in 34 quarters.
Riverbridge Partners's US Physical Therapy position peaked at $56.2M in Q3 2018.
240 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2025.

Based on Riverbridge Partners's 13F filing for Q2 2025, filed 15 Jul 2025.